← Insider buys
ARQT

Arcutis Biotherapeutics, Inc. · Healthcare

Insider Todd Watanabe sold $75K of Arcutis Biotherapeutics, Inc.

Sold$74,893
$23.61Price
3,172Shares

What ARQT did after the filing

Filed May 6Copier in May 7
The stock from Thu, May 7 open, $22.82
+16.8%
S&P 500, same days
+1.3%

Measured over 30 trading days, to the Jun 22 close.

Traded Mon, May 4. Filed Wed, May 6, 6:06 PM ET, after the close. Returns use the May 7 open and the Jun 22 close. Not investment advice.